Europe Trypsin Market Size, Share & Trends Analysis Report By Source (Bovine, Porcine and Others), By Application, By End-Use (Industrial use, Research and Diagnostics), By Country and Growth Forecast, 2024 - 2031

The Europe Trypsin Market is projected to witness market growth of 4.9% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Trypsin Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $8.23 million by 2031. The UK market is exhibiting a CAGR of 4% during (2024 - 2031). Additionally, The France market is projected to experience a CAGR of 5.7% during (2024 - 2031).



In molecular biology and proteomics, trypsin is employed for protein digestion to generate peptide fragments suitable for downstream analysis. Its specificity in cleaving peptide bonds after lysine and arginine residues makes trypsin an ideal enzyme for producing peptides of manageable size for mass spectrometry analysis.

Moreover, digesting complex protein mixtures into smaller peptides, trypsin enables the identification, quantification, and characterization of proteins in biological samples. Proteomic studies using trypsin digestion are invaluable for elucidating protein structures, functions, interactions, and post-translational modifications, thereby advancing our understanding of cellular processes and disease mechanisms.

Belgium’s growing pharmaceutical sector boosts the domestic demand for trypsin, which is essential for various drug development, manufacturing, and research applications. Local pharmaceutical companies’ expanding operations lead to higher consumption of trypsin. According to the International Trade Administration (ITA), Belgium’s industry spends $1.64 billion (€1.5 billion) on R&D annually, equivalent to 40 percent of all private investment made in Belgium.

List of Key Companies Profiled

• Merck Millipore (Merck KGaA)
• Novozymes A/S (Novo Holdings A/S)
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• Promega Corporation
• Takara Bio Inc. (Takara Holdings Inc.)
• Sartorius AG
• PromoCell GmbH
• Geno Technology, Inc.
• Bio-Rad Laboratories, Inc.

Market Report Segmentation

By Source

• Bovine
• Porcine
• Others

By Application

• Biotechnology & Pharmaceutical Industry
• Food Industry
• Cosmetics & Personal Care
• Waste Treatment
• Others

By End-use

• Industrial use
• Research
• Diagnostics

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe